Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) Study

American Journal of Epidemiology

Volumn 168, Issue 10, 2008, Pages 1153-1160

  Tamariz, Leonardo J ^a   Young, J Hunter ^b,c   Pankow, James S ^d   Yeh, Hsin Chieh ^c   Schmidt, Maria Ines ^e   Astor, Brad ^c   Brancati, Frederick L ^b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Blood viscosity; Diabetes mellitus, type 2; Hematocrit; Insulin resistance; Metabolic syndrome X; Oxidative phosphorylation

Indexed keywords

GLUCOSE; INSULIN; OXYGEN; PLASMA PROTEIN;

BLOOD; DIABETES; HEALTH RISK; METABOLISM; PROTEIN; VISCOSITY;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD VISCOSITY; DISEASE PREDISPOSITION; FEMALE; HEMATOCRIT; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR; BLOOD; CLASSIFICATION; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; INCIDENCE; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; QUESTIONNAIRE; UNITED STATES;

ATHEROSCLEROSIS; BLOOD VISCOSITY; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMATOCRIT; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; QUESTIONNAIRES; RISK FACTORS; UNITED STATES;

EID: 56149112349     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn243     Document Type: Article

References (74)

1. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med. 1993;329(27):1988- 1992.
2. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
3. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106(2):171-176.
4. Yang YJ, Hope ID, Ader M, et al. Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest. 1989;84(5):1620-1628.
5. Schultz TA, Lewis SB, Westbie DK, et al. Glucose delivery: a modulator of glucose uptake in contracting skeletal muscle. Am J Physiol. 1977;233(6):E514-E518.
6. Baron AD, Clark MG. Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr. 1997;17:487-499.
7. Stuart J, Kenny MW. Blood rheology. J Clin Pathol. 1980; 33(5):417-429.
8. Høieggen A, Fossum E, Moan A, et al. Whole-blood viscosity and the insulin-resistance syndrome. J Hypertens. 1998;16(2): 203-210.
9. Choi KM, Lee J, Kim YH, et al. Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul (SWS) Study. Diabetes Res Clin Pract. 2003;60(3):205-212.
10. Caimi G, Sinagra D, Scarpitta AM, et al. Plasma viscosity and insulin resistance in metabolic syndrome. Int J Obes Relat Metab Disord. 2001;25(12):1856-1857.
11. Nordby G, Moan A, Kjeldsen SE, et al. Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women. Am J Hypertens. 1995;8(5 pt 1):439-444.
12. Catalano C, Muscelli E, Natali A, et al. Reciprocal association between insulin sensitivity and the haematocrit in man. Eur J Clin Invest. 1997;27(7):634-637.
13. Smith S, Julius S, Jamerson K, et al. Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan. J Hypertens. 1994;12(4):455-462.
14. Facchini FS, Carantoni M, Jeppesen J, et al. Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism. 1998;47(7):831-835.
15. Capoǧlu I, Unüvar N, Bektaş Y, et al. The effects of high haematocrit levels on glucose metabolism disorders. J Int Med Res. 2002;30(4):433-437.
16. Pérez-Martin A, Dumortier M, Pierrisnard E, et al. Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance? Clin Hemorheol Microcirc. 2001;25(3-4):91-103.
17. Wannamethee SG, Perry IJ, Shaper AG. Hematocrit and risk of NIDDM. Diabetes. 1996;45(5):576-579.
18. Tulloch-Reid MK, Hanson RL, Saremi A, et al. Hematocrit and the incidence of type 2 diabetes in the Pima Indians. Diabetes Care. 2004;27(9):2245-2246.
19. Medalie JH, Papier CM, Goldbourt U, et al. Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med. 1975;135(6):811-817.
20. Wilson PW, McGee DL, Kannel WB. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: the Framingham Study. Am J Epidemiol. 1981;114(5): 697-704.
21. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129(4):687-702.
22. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936-942.
23. Nägele U, Hägele EO, Sauer G, et al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22(2): 165-174.
24. 2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. Am J Clin Pathol. 1982;78(5):718-723.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
26. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
27. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem. 1949;177(2):751-766.
28. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual No. 10: Clinical Chemistry Determinations. Version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987:25-28.
29. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities Study (ARIC). Operations Manual No. 4: Pulmonary Function Assessment. Version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.
30. de Simone G, Devereux RB, Chien S, et al. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation. 1990;81(1):107-117.
31. Moan A, Nordby G, Os I, et al. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism. 1994;43(4):423-427.
32. Chien S. Shear dependence of effective cell volume as a determinant of blood viscosity. Science. 1970;168(934): 977-979.
33. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2000;23(suppl 1):S4-S19.
34. Lindsey JC, Ryan LM. Tutorial in biostatistics methods for interval-censored data. Stat Med. 1998;17(2):219-238.
35. Allison PDD. Survival Analysis Using the SAS System. Cary, NC: SAS Publishing; 1995.
36. Letcher RL, Chien S, Pickering TG, et al. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med. 1981;70(6):1195-1202.
37. Guyton A, Hall J. Textbook of Medical Physiology. 10th ed. Philadelphia, PA: WB Saunders Company; 2000.
38. Cinar Y, Senyol AM, Duman K. Blood viscosity and blood pressure: role of temperature and hyperglycemia. Am J Hypertens. 2001;14(5 pt 1):433-438.
39. Cinar Y, Demir G, Pac M, et al. Effect of hematocrit on blood pressure via hyperviscosity. Am J Hypertens. 1999;12(7):739-743.
40. Clark MG, Wallis MG, Barrett EJ, et al. Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab. 2003;284(2):E241-E258.
41. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet. 1989;1(8639):637-639.
42. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem. 1992;61:1175-1212.
43. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300(5622):1140-1142.
44. Barazzoni R, Short KR, Nair KS. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J Biol Chem. 2000;275(5):3343-3347.
45. Gerbitz KD, Gempel K, Brdiczka D. Mitochondria and diabetes - genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes. 1996;45(2):113-126.
46. Iossa S, Mollica MP, Lionetti L, et al. A possible link between skeletal muscle mitochondrial efficiency and age-induced insulin resistance. Diabetes. 2004;53(11):2861-2866.
47. Morino K, Petersen KF, Dufour S, et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest. 2005;115(12):3587-3593.
48. Kelley DE, He J, Menshikova EV, et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51(10):2944- 2950.
49. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267-273.
50. Sparks LM, Xie H, Koza RA, et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes. 2005;54(7):1926-1933.
51. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A. 2003;100(14):8466-8471.
52. Petersen KF, Dufour S, Befroy D, et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350(7):664-671.
53. Bruce CR, Anderson MJ, Carey AL, et al. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab. 2003;88(11):5444-5451.
54. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307(5708):384-387.
55. Short KR, Nair KS, Stump CS. Impaired mitochondrial activity and insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350(23):2419-2421.
56. Simoneau JA, Colberg SR, Thaete FL, et al. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J. 1995;9(2):273-278.
57. Kelley DE, Slasky BS, Janosky J. Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1991;54(3):509-515.
58. Eriksson KF, Lindgärde F. Impaired glucose tolerance in a middle-aged male urban population: a new approach for identifying high-risk cases. Diabetologia. 1990;33(9):526-531.
59. Wisløff U, Najjar SM, Ellingsen O, et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science. 2005;307(5708):418-420.
60. Wong TY, Shankar A, Klein R, et al. Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med. 2005;165(9):1060-1065.
61. Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA. 2002;287(19):2528-2533.
62. Yusuf S, Gerstein H, Hoogwerf B, et al. Ramipril and the development of diabetes. JAMA. 2001;286(15):1882-1885.
63. Vermes E, Ducharme A, Bourassa MG, et al. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation. 2003;107(9):1291- 1296.
64. Lindsay RS, Krakoff J, Hanson RL, et al. Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes. 2001;50(7):1598-1603.
65. Young PM, Rose MS, Sutton JR, et al. Operation Everest II: plasma lipid and hormonal responses during a simulated ascent of Mt. Everest. J Appl Physiol. 1989;66(3):1430-1435.
66. Sawhney RC, Malhotra AS, Singh T. Glucoregulatory hormones in man at high altitude. Eur J Appl Physiol Occup Physiol. 1991;62(4):286-291.
67. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165(5):670-676.
68. Yeh HC, Punjabi NM, Wang NY, et al. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2005;28(6): 1472-1479.
69. Manson JE, Ajani UA, Liu S, et al. A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med. 2000;109(7):538-542.
70. Rimm EB, Chan J, Stampfer MJ, et al. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995;310(6979):555-559.
71. Facchini FS. Effect of phlebotomy on plasma glucose and insulin concentrations. Diabetes Care. 1998;21(12):2190.
72. Fernández-Real JM, Peñarroja G, Castro A, et al. Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes. 2002;51(4):1000-1004.
73. Vozarova B,Weyer C, Lindsay RS, et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002; 51(2):455-461.
74. Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes. 2003;52(7):1799-1805.